Hormone replacement therapy and antidepressant prescription patterns: A reciprocal relationship

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 1, 2005, Pages 57-59

  McIntyre, Roger S ^a,d   Konarski, Jakub Z ^c   Grigoriadis, Sophie ^a,b   Fan, Nancy C ^a   Mancini, Deborah A ^a   Fulton, Kari A ^a   Stewart, Donna E ^a,b   Kennedy, Sidney H ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; CLIMACTERIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INFORMATION; ESTROGEN THERAPY; HUMAN; INVOLUTIONAL DEPRESSION; MAJOR DEPRESSION; MEDICAL PRACTICE; MENOPAUSE; NOTE; PRESCRIPTION; PSYCHOLOGIC ASSESSMENT; PUBLICATION; STATISTICAL SIGNIFICANCE;

EID: 12344307605     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040517     Document Type: Note

References (33)

1. Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments (CANMAT). Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry 2001;46(Suppl 1):5S-90S.
2. Bebbington P, Wilkins S, Sham P, Jones P, van Os J, Murray R, Toone B, Lewis S. Life events before psychotic episodes: Do clinical and social variables affect the relationship? Soc Psychiatry Psychiatr Epidemiol 1996;31(3-4):122-8.
3. Bebbington P, Dunn G, Jenkins R, Lewis G, Brugha T, Farrell M, Meltzer H. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int Rev Psychiatry 2003;15(1-2):74-83.
4. Kendler KS, Gardner CO, Prescott CA. Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 2002;159(7):1133-45.
5. Brown ES, Varghese FP, McEwen BS. Association of depression with medical illness: Does cortisol play a role? Biol Psychiatry 2004;55(1):1-9.
6. Altshuler LL. The use of SSRIs in depressive disorders specific to women. J Clin Psychiatry 2002;63(Suppl 7):3-8.
7. Kornstein SG, Sloan DM, Thase ME. Gender-specific differences in depression and treatment response. Psychopharmacol Bull 2002;36(4 Suppl 3):99-112.
8. Grigoriadis S, Kennedy SH, Bagby RM. A comparison of antidepressant response in younger and older women. J Clin Psychopharmacol 2003;23(4):405-7.
9. Sloan DM, Kornstein SG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003;26(3):581-94.
10. Burt VK, Altshuler LL, Rasgon N. Depressive symptoms in the perimenopause: prevalence, assessment, and guidelines for treatment. Harv Rev Psychiatry 1998;6(3):121-32.
11. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 2000;183(2):414-20.
12. Kendall DA, Stancel GM, Enna SJ. The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J Neurosci 1982;2(3):354-60.
13. McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48(5 Suppl 7):S8-15.
14. Chakravorty SG, Halbreich U. The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 1997;33(2):229-33.
15. Halbreich U, Kahn LS. Selective oestrogen receptor modulators - current and future brain and behaviour applications. Expert Opin Pharmacother 2000;1(7):1385-98.
16. Winterhoff H, Spengler B, Christoffel V, Butterweck V, Lohning A. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity. Maturitas 2003;44(Suppl 1):S51-S58.
17. Reynolds RF, Walker AM, Obermeyer CM, Rahman O, Guilbert D. Discontinuation of postmenopausal hormone therapy in a Massachusetts HMO. J Clin Epidemiol 2001;54(10):1056-64.
18. Weitzner MA, Moncello J, Jacobsen PB, Minton S. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;23(4):337-45.
19. Stoppe G, Doren M. Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Women Ment Health 2002;5(2):39-47.
20. Stearns V, Beebe KL, Iyengar M, Dube E. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA 2003;289(21):2827-34.
21. Campbell S, Whitehead M. Oestrogens for menopausal flushing. BMJ 1977;1 (6053):104-5.
22. Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157(6):924-30.
23. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression? J R Coll Gen Pract 1981;31(224):134-40.
24. Pearce J, Hawton K, Blake F, Barlow D, Rees M, Fagg J, Keenan J. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study. J Psychosom Res 1997;42(2):177-86.
25. Smith RN, Studd JW, Zamblera D, Holland EF. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol 1995;102(6):475-84.
26. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347 (9006):930-3.
27. Cohen LS, Soares CN, Poitras JR, Prouty J, Alexander AB, Shifren JL. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry 2003;160(8):1519-22.
28. Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58(6):529-34.
29. Rasgon NL, Altshuler LL, Fairbanks L. Estrogen-replacement therapy for depression. Am J Psychiatry 2001;158(10):1738.
30. Pinkerton JV, Santen R. Use of alternatives to estrogen for treatment of menopause. Minerva Endocrinol 2002;27(1):21-41.
31. Diagnostic and statistical manual of mental disorders. 4th ed, text revision. Washington: American Psychiatric Association; 2000.
32. The North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11(1):11-33.
33. Thorpe L, Whitney DK, Kutcher SP, Kennedy SH. Clinical guidelines for the treatment of depressive disorders. VI. Special populations. Can J Psychiatry 2001;46(Suppl 1):63S-76S.